{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:43:59Z","timestamp":1793731439817,"version":"4.6.1"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Boron neutron capture therapy (BNCT), a precision radiotherapy modality, has shown significant promise in targeted cancer treatment. Like conventional radiotherapy, the development of radioresistance hinders the efficacy of BNCT. Nevertheless, the physical parameters in BNCT induce the massive anti-tumor response compared to low-LET radiotherapy. Recent advancements have highlighted its synergistic potential with immunotherapy. In this review, we explore how the unique physical-to-biological trajectory of BNCT drives a potent \u201cCold-to-Hot\u201d transformation of the tumor microenvironment. We describe how radiotherapy remodels the tumor microenvironment and extrapolate the potential mechanism by which BNCT influences anti-tumor response based on the principles of conventional radiotherapy. BNCT-induced immunogenic cell death and neoantigen presentation activate dendritic cells and CD8\n                    <jats:sup>\u207a<\/jats:sup>\n                    T-cells. Besides its immunostimulatory effects, BNCT may also exhibit immunosuppressive effects. Both the recruitment of immunosuppressive cells and tumor hypoxia can influence BNCT efficacy, and studies have shown that targeting these factors can enhance BNCT outcomes. Looking forward, we propose that combining BNCT with CAR-T cell therapy or immune checkpoint inhibitors represents one of the most promising directions for its future application. We hope this review provides novel insights into the clinical translation of BNCT.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1687072","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:15:29Z","timestamp":1779948929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Boron neutron capture therapy combined with immunotherapy: insights from radiotherapy, BNCT-specific evidence, and future directions"],"prefix":"10.3389","volume":"17","author":[{"given":"Zeyuan","family":"Li","sequence":"first","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Cai","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiukui","family":"Cheng","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linping","family":"Qi","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingda","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]},{"name":"Gansu Provincial Key Laboratory of Environmental Oncology","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]},{"name":"Department of Orthopedics, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216268","article-title":"Particle radiotherapy in the era of radioimmunotherapy","volume":"567","author":"Zhou","year":"2023","journal-title":"Cancer Lett"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12089","article-title":"Boron neutron capture therapy: current status and future perspectives","volume":"40","author":"Dymova","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1039\/d5tb00478k","article-title":"Lyophilized tumour cell-loaded (10)B-doped carbon dots for simultaneous boron neutron capture therapy and enhancement of antitumor immunity of prostate cancer","volume":"13","author":"Yang","year":"2025","journal-title":"J Mater Chem B"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202419418","article-title":"A PD-L1 siRNA-loaded boron nanoparticle for targeted cancer radiotherapy and immunotherapy","volume":"37","author":"Deng","year":"2025","journal-title":"Advanced Materials (Deerfield Beach Fla)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.788770","article-title":"Boron neutron capture therapy: current status and challenges","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1259\/bjr\/56953620","article-title":"Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential","volume":"83","author":"Sk\u00f6ld","year":"2010","journal-title":"Br J Radiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40880-018-0299-7","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun (London England)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1515\/mr-2023-0013","article-title":"Nanostructured boron agents for boron neutron capture therapy: a review of recent patents","volume":"3","author":"Zhang","year":"2023","journal-title":"Med Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244029","article-title":"Boron vehiculating nanosystems for neutron capture therapy in cancer treatment","volume":"11","author":"Ailuno","year":"2022","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12951-024-02397-5","article-title":"Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy","volume":"22","author":"Wr\u00f3blewska","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/s41467-023-37253-x","article-title":"Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy","volume":"14","author":"Shi","year":"2023","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2025.112118","article-title":"Extended follow-up of recurrent glioblastoma patients treated with boron neutron capture therapy (BNCT): long-term survival from a phase II trial (JG002) using cyclotron neutron source and boronophenylalanine","volume":"226","author":"Kawabata","year":"2025","journal-title":"Appl Radiat Isotopes: Including Data Instrumentation Methods For Use Agriculture Industry Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-31334-9_24","article-title":"BNCT for advanced or recurrent head and neck cancer","volume":"88","author":"Aihara","year":"2014","journal-title":"Appl Radiat Isotopes: Including Data Instrumentation Methods For Use Agriculture Industry Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2020.109407","article-title":"BNCT for primary synovial sarcoma","volume":"169","author":"Fujimoto","year":"2021","journal-title":"Appl Radiat Isotopes: Including Data Instrumentation Methods For Use Agriculture Industry Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110607","article-title":"Boron neutron capture therapy for cutaneous angiosarcoma and Malignant melanoma: first in-human phase I clinical trial","volume":"202","author":"Kashihara","year":"2025","journal-title":"Radiotherapy Oncol J Eur Soc For Ther Radiol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-induced tumor immune microenvironments and potential targets for combination therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133212","article-title":"Tumor microenvironment as a \"game changer\" in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0040","article-title":"Enhancing cancer therapy: boron-rich polyboronate ester micelles for synergistic boron neutron capture therapy and PD-1\/PD-L1 checkpoint blockade","volume":"28","author":"Chiu","year":"2024","journal-title":"Biomater Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med Res Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00075-5","article-title":"Radiotherapy, immunity, and immune checkpoint inhibitors","volume":"25","author":"Lynch","year":"2024","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.04.003","article-title":"Radiation therapy-induced remodeling of the tumor immune microenvironment","volume":"86","author":"Charpentier","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00411-017-0704-7","article-title":"Abscopal effect of boron neutron capture therapy (BNCT): proof of principle in an experimental model of colon cancer","volume":"56","author":"Trivillin","year":"2017","journal-title":"Radiat Environ Biophys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1263873","article-title":"Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model","volume":"13","author":"Chang","year":"2023","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/a:1006488301412","article-title":"Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells","volume":"46","author":"Smilowitz","year":"2000","journal-title":"J Neuro-Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/life13071538","article-title":"Therapeutic efficacy, radiotoxicity and abscopal effect of BNCT at the RA-3 nuclear reactor employing oligo-fucoidan and glutamine as adjuvants in an ectopic colon cancer model in rats","volume":"13","author":"Frydryk Benitez","year":"2023","journal-title":"Life (Basel Switzerland)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210593","article-title":"Evaluation of local, regional and abscopal effects of boron neutron capture therapy (BNCT) combined with immunotherapy in an ectopic colon cancer model","volume":"94","author":"Trivillin","year":"2021","journal-title":"Br J Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2022.6","article-title":"Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair","volume":"24","author":"Nikitaki","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.07123","article-title":"Formation of clustered DNA damage after high-LET irradiation: a review","volume":"49","author":"Hada","year":"2008","journal-title":"J Radiat Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1667\/rr3041.1","article-title":"Induction and repair of clustered DNA lesions: what do we know so far","volume":"180","author":"Georgakilas","year":"2013","journal-title":"Radiat Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/imr.13271","article-title":"Molecular determinants of immunogenic cell death elicited by radiation therapy","volume":"321","author":"Galassi","year":"2024","journal-title":"Immunol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228877","article-title":"The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer","volume":"21","author":"Storozynsky","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232101","article-title":"Radiotherapy and immunology","volume":"221","author":"Wang","year":"2024","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-159-6_9","article-title":"Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell Mol Life Sciences: CMLS"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02519-z","article-title":"Cancer cell-intrinsic STING is associated with CD8\u2009+\u2009T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma","volume":"23","author":"Zhang","year":"2021","journal-title":"Clin Trans Oncol Off Publ Fed Spanish Oncol Societies Natl Cancer Institute Mexico"},{"key":"B43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41420-022-01256-2","article-title":"Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS\/STING in non-small cell lung cancer","volume":"8","author":"Han","year":"2022","journal-title":"Cell Death Discov"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41467-025-67984-y","article-title":"Boron neutron capture therapy preserves immune cells and induces robust anti-tumour immunity in preclinical mouse model","volume":"17","author":"Sun","year":"2026","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405158","article-title":"Boron neutron capture therapy-derived extracellular vesicles via DNA accumulation boost antitumor dendritic cell vaccine efficacy","volume":"11","author":"Lv","year":"2024","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1440559","article-title":"Fractionated alpha and mixed beam radiation promote stronger pro-inflammatory effects compared to acute exposure and trigger phagocytosis","volume":"18","author":"Karimi Roshan","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12951-025-03916-8","article-title":"Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy","volume":"24","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"iScience"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/biology11030420","article-title":"Extracellular release of HMGB1 as an early potential biomarker for the therapeutic response in a xenograft model of boron neutron capture therapy","volume":"11","author":"Imamichi","year":"2022","journal-title":"Biology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1391046","article-title":"DNA sensing of dendritic cells in cancer immunotherapy","volume":"11","author":"Qian","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-022-01264-9","article-title":"Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci138740","article-title":"Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control","volume":"131","author":"Lhuillier","year":"2021","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.6338","article-title":"Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy","volume":"170","author":"Chakraborty","year":"2003","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/bs.apcsb.2018.11.004","article-title":"Mechanistic link between DNA damage sensing, repairing and signaling factors and immune signaling","volume":"115","author":"Mukherjee","year":"2019","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218151","article-title":"Immunomodulatory effects of radiotherapy","volume":"21","author":"Kumari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2021.1956004","article-title":"HIF-1\u03b1 affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA","volume":"97","author":"Sanada","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-21-1105","article-title":"Myeloid-derived suppressor cells and radiotherapy","volume":"10","author":"Jim\u00e9nez-Cortegana","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpt.2024.100633","article-title":"The level of circulating M-MDSCs as an indicator for the therapeutic outcome of BNCT in end-stage Malignant brain tumor patients","volume":"14","author":"Chang","year":"2024","journal-title":"Int J Particle Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2018.01.071","article-title":"Targeting myeloid-derived suppressor cells and programmed death ligand 1 confers therapeutic advantage of ablative hypofractionated radiation therapy compared with conventional fractionated radiation therapy","volume":"101","author":"Lan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175130","article-title":"Circulating M-MDSC levels as an assessment marker for post-treatment tumor progression in recurrent HNC patients following radiation therapy: a case series","volume":"13","author":"Chang","year":"2024","journal-title":"J Clin Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.610104","article-title":"Myeloid-derived suppressor cells: a new and pivotal player in colorectal cancer progression","volume":"10","author":"Yin","year":"2020","journal-title":"Front Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn6758","article-title":"Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma","volume":"15","author":"Ghosh","year":"2023","journal-title":"Sci Transl Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03154","article-title":"Overcoming resistance to combination radiation-immunotherapy: a focus on contributing pathways within the tumor microenvironment","volume":"9","author":"Darragh","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.11.038","article-title":"Polymorphonuclear-MDSCs facilitate tumor regrowth after radiation by suppressing CD8(+) T cells","volume":"109","author":"Zhang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.09.026","article-title":"PD-L1: from cancer immunotherapy to therapeutic implications in multiple disorders","volume":"32","author":"Lee","year":"2024","journal-title":"Mol Therapy: J Am Soc Gene Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-23-3206","article-title":"Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites","volume":"30","author":"Hou","year":"2024","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02244-8","article-title":"Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma","volume":"128","author":"Yamamoto","year":"2023","journal-title":"Br J Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104453119","article-title":"Expression of H(v)1 proton channels in myeloid-derived suppressor cells (MDSC) and its potential role in T cell regulation","volume":"119","author":"Alvear-Arias","year":"2022","journal-title":"PNAS"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1129997","article-title":"In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators","volume":"14","author":"Zaki","year":"2023","journal-title":"Front Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100940","article-title":"Innate immunity: looking beyond T-cells in radiation and immunotherapy combinations","volume":"46","author":"McMahon","year":"2023","journal-title":"Neoplasia (New York NY)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1330099","article-title":"A new target of radiotherapy combined with immunotherapy: regulatory T cells","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-2-8","article-title":"Role of CD28\/B7 costimulation and IL-12\/IL-10 interaction in the radiation-induced immune changes","volume":"2","author":"Liu","year":"2001","journal-title":"BMC Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.urols.2015.06.230","article-title":"TGF-\u03b21 mediates the radiation response of prostate cancer","volume":"93","author":"Wu","year":"2015","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03313-2","article-title":"Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy","volume":"72","author":"Rutihinda","year":"2023","journal-title":"Cancer Immunology Immunotherapy: CII"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S421173","article-title":"Macrophages as promising carriers for nanoparticle delivery in anticancer therapy","volume":"18","author":"Wr\u00f3blewska","year":"2023","journal-title":"Int J Nanomed"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-11-1792","article-title":"Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment","volume":"72","author":"Lesokhin","year":"2012","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019495","article-title":"Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222022","article-title":"BNCT induced immunomodulatory effects contribute to mammary tumor inhibition","volume":"14","author":"Khan","year":"2019","journal-title":"PloS One"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-023-02097-3","article-title":"Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review","volume":"199","author":"Becherini","year":"2023","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2018.01.004","article-title":"Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms","volume":"9","author":"Miszczyk","year":"2018","journal-title":"Clin Trans Radiat Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12951-022-01304-0","article-title":"Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma","volume":"20","author":"Chen","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051102","article-title":"Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing","volume":"13","author":"Kabakov","year":"2021","journal-title":"Cancers"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2024.255","article-title":"Role of HIF-1\u03b1 in the responses of tumors to radiotherapy and chemotherapy","volume":"57","author":"Song","year":"2025","journal-title":"Cancer Res Treat"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers13153833","article-title":"Involvement of HIF-1\u03b1 in the detection, signaling, and repair of DNA double-strand breaks after photon and carbon-ion irradiation","volume":"13","author":"Wozny","year":"2021","journal-title":"Cancers"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1999.00845.x","article-title":"Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain","volume":"11","author":"Bergeron","year":"1999","journal-title":"Eur J Neurosci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141057","article-title":"Influence of hypoxia on tumor heterogeneity, DNA repair, and cancer therapy: from molecular insights to therapeutic strategies","volume":"14","author":"Kunachowicz","year":"2025","journal-title":"Cells"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/685308","article-title":"Microenvironment and radiation therapy","volume":"2013","author":"Yoshimura","year":"2013","journal-title":"BioMed Res Int"},{"key":"B98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","article-title":"Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma","volume":"80","author":"Zhang","year":"2024","journal-title":"J Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.893265","article-title":"Hypoxia-inducible factor-1\u03b1 protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia","volume":"21","author":"Fu","year":"2015","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0168","article-title":"Radiotherapy to enhance chimeric antigen receptor T-cell therapeutic efficacy in solid tumors: A narrative review","volume":"7","author":"Hauth","year":"2021","journal-title":"JAMA Oncol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","article-title":"Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder","volume":"167","author":"T\u0103rlungeanu","year":"2016","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171371","article-title":"Endothelial cell-specific LAT1 ablation normalizes tumor vasculature","volume":"9","author":"Suehiro","year":"2024","journal-title":"JCI Insight"},{"key":"B106","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/cji.0000000000000284","article-title":"Radiation priming chimeric antigen receptor T-cell therapy in relapsed\/refractory diffuse large B-cell lymphoma with high tumor burden","volume":"43","author":"Qu","year":"2020","journal-title":"J Immunotherapy (Hagerstown Md: 1997)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40425-019-0698-6","article-title":"Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition","volume":"7","author":"Newton","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad118","article-title":"Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations","volume":"115","author":"Karapetyan","year":"2023","journal-title":"J Natl Cancer Institute"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35561","article-title":"Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review","volume":"130","author":"Abyaneh","year":"2024","journal-title":"Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.medj.2024.06.002","article-title":"Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Med (New York NY)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor151","article-title":"Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)","volume":"115","author":"Fujimoto","year":"2024","journal-title":"Cancer Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12943-023-01775-1","article-title":"CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks","volume":"22","author":"Hovhannisyan","year":"2023","journal-title":"Mol Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.813832","article-title":"CAR-T plus radiotherapy: A promising combination for immunosuppressive tumors","volume":"12","author":"Qin","year":"2021","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.2mr0220-549r","article-title":"ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukocyte Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(99)70070-3","article-title":"VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis","volume":"116","author":"Sans","year":"1999","journal-title":"Gastroenterology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijrobp.2016.10.043","article-title":"Intercellular adhesion molecule-1 and vascular cell adhesion molecule are induced by ionizing radiation on lymphatic endothelium","volume":"97","author":"Rodriguez-Ruiz","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B118","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijrobp.2021.07.1598","article-title":"Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients","volume":"19","author":"Saeed","year":"2024","journal-title":"Radiat Oncol (London England)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c12640","article-title":"Coupling adoptive cell therapy with boron neutron capture therapy: Using functional tumor-infiltrating lymphocytes for tumor delivery of boron carbide nanoparticles","volume":"19","author":"Demichelis","year":"2025","journal-title":"ACS Nano"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2024.111648","article-title":"Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapy","volume":"218","author":"Imamichi","year":"2025","journal-title":"Appl Radiat Isotopes: Including Data Instrumentation Methods For Use Agriculture Industry Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.1157","article-title":"Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa068","article-title":"Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)","volume":"61","author":"Hiratsuka","year":"2020","journal-title":"J Radiat Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10764.x","article-title":"Results of carbon ion radiotherapy for skin carcinomas in 45 patients","volume":"166","author":"Zhang","year":"2012","journal-title":"Br J Dermatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705361","article-title":"Immunogenic cell death induction by ionizing radiation","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrw022","article-title":"An analysis of the structure of the compound biological effectiveness factor","author":"Ono","year":"2016","journal-title":"J Radiat Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112883","article-title":"Response of normal tissues to boron neutron capture therapy (BNCT) with (10)B-borocaptate sodium (BSH) and (10)B-paraboronophenylalanine (BPA)","volume":"10","author":"Fukuda","year":"2021","journal-title":"Cells"},{"key":"B127","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13014-021-01939-7","article-title":"The basis and advances in clinical application of boron neutron capture therapy","volume":"16","author":"He","year":"2021","journal-title":"Radiat Oncol (London England)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2025.111720","article-title":"Comparison of dose distribution with and without reflecting heterogeneous boron distribution using (18)F-BPA positron emission tomography in boron neutron capture therapy","volume":"219","author":"Kobayashi","year":"2025","journal-title":"Appl Radiat Isotopes: Including Data Instrumentation Methods For Use Agriculture Industry Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-1769","article-title":"Prognostic assessment of (18)F-boronophenylalanine positron emission tomography (BPA-PET) in salvage boron neutron capture therapy for Malignant brain tumors","volume":"14","author":"Lin","year":"2024","journal-title":"Quantitative Imaging Med Surg"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12581","article-title":"Boron neutron capture therapy of cancer: where do we stand now","volume":"44","author":"Barth","year":"2024","journal-title":"Cancer Commun (London England)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"71","DOI":"10.14338\/ijpt-22-00002.1","article-title":"A review of boron neutron capture therapy: its history and current challenges","volume":"9","author":"Jin","year":"2022","journal-title":"Int J Particle Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.04.033","article-title":"Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival","volume":"137","author":"Koivunoro","year":"2019","journal-title":"Radiotherapy Oncol J Eur Soc For Ther Radiol Oncol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14338\/ijpt-19-00057","article-title":"Hypofractionated proton therapy in early prostate cancer: Results of a phase I\/II trial at Loma Linda University","volume":"6","author":"Slater","year":"2019","journal-title":"Int J Particle Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1687072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:15:32Z","timestamp":1779948932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1687072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":133,"alternative-id":["10.3389\/fimmu.2026.1687072"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1687072","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1687072"}}